Related references
Note: Only part of the references are listed.C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration A Randomized Pivotal Phase 2/3 Trial
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2021)
Therapeutic Options Under Development for Nonneovascular Age-Related Macular Degeneration and Geographic Atrophy
Joon-Bom Kim et al.
DRUGS & AGING (2021)
Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor Pegcetacoplan
Nathan C. Steinle et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)
Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy
Charles C. Wykoff et al.
OPHTHALMOLOGY (2021)
Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
Ana Bety Enriquez et al.
JAMA OPHTHALMOLOGY (2021)
Beyond factor H: The impact of genetic-risk variants for age-related macular degeneration on circulating factor-H-like 1 and factor-H-related protein concentrations
Valentina Cipriani et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2021)
Pegcetacoplan: First Approval
Sheridan M. Hoy
DRUGS (2021)
Complement System and Potential Therapeutics in Age-Related Macular Degeneration
Young Gun Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Pigment epithelium-derived factor (PEDF) and derived peptides promote survival and differentiation of photoreceptors and induce neurite-outgrowth in amacrine neurons
German Michelis et al.
JOURNAL OF NEUROCHEMISTRY (2021)
A Review of Completed and Ongoing Complement Inhibitor Trials for Geographic Atrophy Secondary to Age-Related Macular Degeneration
Omar A. Halawa et al.
JOURNAL OF CLINICAL MEDICINE (2021)
A Framework for Multiscale Quantitation of Relationships Between Choriocapillaris Flow Impairment and Geographic Atrophy Growth
Eric M. Moult et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2020)
Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease
Esther C. W. de Boer et al.
FRONTIERS IN IMMUNOLOGY (2020)
Altered Protein Function Caused by AMD-associated Variant rs704 Links Vitronectin to Disease Pathology
Fabiola Biasella et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2020)
Complement inhibition as a therapeutic strategy in retinal disorders
Enoch Kassa et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules
Marcella Nebbioso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Correlations between Choriocapillaris Flow Deficits around Geographic Atrophy and Enlargement Rates Based on Swept-Source OCT Imaging
Marie Thulliez et al.
OPHTHALMOLOGY RETINA (2019)
HTRA1, an age-related macular degeneration protease, processes extracellular matrix proteins EFEMP1 and TSP1
Michael K. Lin et al.
AGING CELL (2018)
Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation
Laura Lores-Motta et al.
OPHTHALMOLOGY (2018)
Complement factor H in AMD: Bridging genetic associations and pathobiology
Christopher B. Toomey et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2018)
Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration Chroma and Spectri Phase 3 Randomized Clinical Trials
Frank G. Holz et al.
JAMA OPHTHALMOLOGY (2018)
Self-Damage Caused by Dysregulation of the Complement Alternative Pathway: Relevance of the Factor H Protein Family
Pilar Sanchez-Corral et al.
FRONTIERS IN IMMUNOLOGY (2018)
Progression of Geographic Atrophy in Age-related Macular Degeneration AREDS2 Report Number 16
Tiarnan D. Keenan et al.
OPHTHALMOLOGY (2018)
Modulatory effects of 1,25-dihydroxyvitamin D3 on eye disorders: A critical review
Marcella Nebbioso et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2017)
Recombinant Haplotypes Narrow the ARMS2/HTRA1 Association Signal for Age-Related Macular Degeneration
Felix Grassmann et al.
GENETICS (2017)
Recombinant Haplotypes Narrow the ARMS2/HTRA1 Association Signal for Age-Related Macular Degeneration
Felix Grassmann et al.
GENETICS (2017)
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants
Lars G. Fritsche et al.
NATURE GENETICS (2016)
Natural History of Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration (Geographic Atrophy Progression Study)
Steffen Schmitz-Valckenberg et al.
OPHTHALMOLOGY (2016)
Antibody therapies and their challenges in the treatment of age-related macular degeneration
Cornelia Volz et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Association Between Subfoveal Choroidal Thickness, Reticular Pseudodrusen, and Geographic Atrophy in Age-Related Macular Degeneration
Mariana R. Thorell et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2015)
The Membrane Attack Complex in Aging Human Choriocapillaris Relationship to Macular Degeneration and Choroidal Thinning
Robert F. Mullins et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration
Zohar Yehoshua et al.
OPHTHALMOLOGY (2014)
Complement System in Pathogenesis of AMD: Dual Player in Degeneration and Protection of Retinal Tissue
Milosz P. Kawa et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
Wan Ling Wong et al.
LANCET GLOBAL HEALTH (2014)
Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration
Morad Ansari et al.
HUMAN MOLECULAR GENETICS (2013)
Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration
Gui-shuang Ying et al.
OPHTHALMOLOGY (2013)
Clinical Classification of Age-related Macular Degeneration
Frederick L. Ferris et al.
OPHTHALMOLOGY (2013)
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
Usha Chakravarthy et al.
OPHTHALMOLOGY (2012)
Association of Genetic Polymorphisms and Age-Related Macular Degeneration in Chinese Population
Jun Tian et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Systematic Review and Meta-Analysis of the Association Between Complement Component 3 and Age-related Macular Degeneration: A HuGE Review and Meta-Analysis
Ammarin Thakkinstian et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
A rare penetrant mutation in CFH confers high risk of age-related macular degeneration
Soumya Raychaudhuri et al.
NATURE GENETICS (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Common Complement C3 Variant Is Associated with Protection against Wet Age-Related Macular Degeneration in a Japanese Population
Suiho Yanagisawa et al.
PLOS ONE (2011)
The Central Portion of Factor H (Modules 10-15) Is Compact and Contains a Structurally Deviant CCP Module
Christoph Q. Schmidt et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
ASSOCIATION STUDY OF COMPLEMENT FACTOR H, C2, CFB, AND C3 AND AGE-RELATED MACULAR DEGENERATION IN A HAN CHINESE POPULATION
Xiaoqi Liu et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Change in Area of Geographic Atrophy in the Age-Related Eye Disease Study
ARCHIVES OF OPHTHALMOLOGY (2009)
Complement Component C2, Inhibiting a Latent Serine Protease in the Classical Pathway of Complement Activation
Maria A. Halili et al.
BIOCHEMISTRY (2009)
Association of C3 Gene Polymorphisms with Neovascular Age-Related Macular Degeneration in a Chinese Population
Xue-Ting Pei et al.
CURRENT EYE RESEARCH (2009)
Complement and immune defense: From innate immunity to human diseases
Peter F. Zipfel
IMMUNOLOGY LETTERS (2009)
The Epidemiology of Progression of Pure Geographic Atrophy: The Beaver Dam Eye Study
Ronald Klein et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
C3 R102G polymorphism increases risk of age-related macular degeneration
Kylee L. Spencer et al.
HUMAN MOLECULAR GENETICS (2008)
Ranibizumab for predominantly classic neovascular age-related macular degeneration: Subgroup analysis of first-year ANCHOR results
Peter K. Kaiser et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Variation in complement factor 3 is associated with risk of age-related macular degeneration
Julian B. Maller et al.
NATURE GENETICS (2007)
The role of complement system in ocular diseases including uveitis and macular degeneration
Purushottam Jha et al.
MOLECULAR IMMUNOLOGY (2007)
Complement C3 variant and the risk of age-related macular degeneration
John R. W. Yates et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration
Zhenglin Yang et al.
SCIENCE (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration
Mingyao Li et al.
NATURE GENETICS (2006)
Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
B Gold et al.
NATURE GENETICS (2006)
Drusen complement components C3a and C5a promote choroidal neovascularization
M Nozaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy
CA Curcio et al.
EXPERIMENTAL EYE RESEARCH (2005)
Y402H polymorphism in complement factor H and age-related macular degeneration (AMD)
HPN Scholl et al.
OPHTHALMOLOGE (2005)
Susceptibility genes for age-related maculopathy on chromosome 10q26
J Jakobsdottir et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration
A Bindewald et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2005)
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
GS Hageman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Complement factor H polymorphism and age-related macular degeneration
AO Edwards et al.
SCIENCE (2005)
Complement factor H variant increases the risk of age-related macular degeneration
JL Haines et al.
SCIENCE (2005)
Ocular immune privilege: Therapeutic opportunities from an experiment of nature
JW Streilein
NATURE REVIEWS IMMUNOLOGY (2003)
Complement activation and inflammatory processes in drusen formation and age related macular degeneration
LV Johnson et al.
EXPERIMENTAL EYE RESEARCH (2001)
Role of free radicals in the neurodegenerative diseases - Therapeutic implications for antioxidant treatment
B Halliwell
DRUGS & AGING (2001)
Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease
RF Mullins et al.
FASEB JOURNAL (2000)
A potential role for immune complex pathogenesis in drusen formation
LV Johnson et al.
EXPERIMENTAL EYE RESEARCH (2000)
Share Paper
